1. Sun, Jian, Yoon, Jaeho, Lee, Moonsup, Hwang, Yoo-Seok, Daar, Ira O. . Zic5 stabilizes Gli3 via a non-transcriptional mechanism during retinal development. In Cell reports, 38, 110312. doi:10.1016/j.celrep.2022.110312. https://pubmed.ncbi.nlm.nih.gov/35108539/
2. Song, Wenping, Yu, Weijiang, Li, Ding, Chen, Jinhua, Zhang, Wenzhou. . ZIC5 promotes human hepatocellular carcinoma cell proliferation through upregulating COL1A1. In Journal of gastrointestinal oncology, 13, 1237-1247. doi:10.21037/jgo-22-335. https://pubmed.ncbi.nlm.nih.gov/35837163/
3. Liu, Limin, Hu, Xingsheng, Sun, Dangze, Wu, Yao, Zhao, Zhanwei. 2018. ZIC5 facilitates the growth of hepatocellular carcinoma through activating Wnt/β-catenin pathway. In Biochemical and biophysical research communications, 503, 2173-2179. doi:10.1016/j.bbrc.2018.08.009. https://pubmed.ncbi.nlm.nih.gov/30086882/
4. Li, Tieqi, Zhang, Gehou, Li, Wei, Tan, Guolin, Ai, Jingang. 2023. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2. In Biological chemistry, 404, 961-975. doi:10.1515/hsz-2022-0329. https://pubmed.ncbi.nlm.nih.gov/36752150/
5. Zhao, Zibo, Wang, Lu, Bartom, Elizabeth, Chandel, Navdeep, Shilatifard, Ali. 2019. β-Catenin/Tcf7l2-dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer. In Science advances, 5, eaax0698. doi:10.1126/sciadv.aax0698. https://pubmed.ncbi.nlm.nih.gov/31392276/
6. Satow, Reiko, Nakamura, Tomomi, Kato, Chiaki, Murayama, Yumi, Fukami, Kiyoko. 2016. ZIC5 Drives Melanoma Aggressiveness by PDGFD-Mediated Activation of FAK and STAT3. In Cancer research, 77, 366-377. doi:10.1158/0008-5472.CAN-16-0991. https://pubmed.ncbi.nlm.nih.gov/27671679/